Research in IGF-1 and IGF-1 LR3 Peptides and Muscle Growth

Research in IGF-1 and IGF-1 LR3 Peptides and Muscle Growth

IGF-1, also known as Insulin-Like Growth Factor 1 or Somatomedin 1, is naturally present in the blood. It is a polypeptide hormone with structural similarity to Insulin. Primarily synthesized in the liver, the synthesis of IGF-1 is managed by the pituitary secretion of Growth Hormone (GH). Various organs, including the brain, are speculated to synthesize IGF-1 locally.

The speculated primary function of IGF-1 is to stimulate growth, potentially causing hypertrophy, an increase in cell size, and hyperplasia, an increase in cell number in most tissues, including bone. The concentration of IGF-1 in serum is believed to increase during periods of developmental growth, reaching its peak upon reproductive maturation, and gradually decreasing.

Various speculative research studies suggest that decreasing levels of IGF-1 may play a role in negative effects associated with the cell aging process. This may include a decline in lean muscle mass and an increase in adipose (fat) tissue. One study split fully mature research models into two groups: one exposed to IGF-1 three times weekly for six months, while the other received no exposure. The impact on the group exposed to IGF-1 were pronounced, showing an 8.8% gain in lean muscle mass and a 14.4% decrease in adipose tissue. Additionally, this group was speculated to experience an average increase of 1.6% in lumbar vertebral bone density and a 7.1% rise in skin thickness. The control group experienced no changes in muscle mass, adiposity, bone density, or skin thickness. This and other studies like it suggest the vital role IGF-1 may play.

IGF-1 LR3 peptide is speculated to be 2-3 times more effective in generating these effects than unmodified IGF-1. IGF-1 LR3 peptide, a more potent form of IGF-1 that has been chemically changed, has been suggested to exhibit significant implications in the enhancement of these effects.

 

IGF-1 LR3 Peptide and Muscle Cell Proliferation

IGF-1 LR3 peptide is widely regarded among researchers as a potential activator of muscle growth. The potential action of IGF-1 LR3 peptide on muscular tissue are not fully understood, but researchers may suggest that it promotes new muscle cells and fibers while supporting the growth and retention of existing muscular tissue. The capacity of IGF-1 LR3 peptide to stimulate muscle cell proliferation, along with its powerful anabolic potential, could distinguish it from other muscle-building compounds.

Under significant muscular stress, the organism may respond by undergoing a process known as hypertrophy, an increase in the size of already existing muscle cells. Crucially, this process may only impact existing muscle cells, with no new muscle cells or fibers formed. However, studies suggest that research models exposed to IGF-1 LR3 peptide, also known as Long R3 IGF-1, may experience an increase in the size of existing muscle cells and the formation of new muscle cells (hyperplasia), along with the growth of new muscle fibers (mitogenesis). In the presence of IGF-1 LR3 peptide exposure, it is speculated that muscular growth may rise considerably, and newly generated muscle cells may increase in size and density.

 

Disclaimer: The products mentioned are not intended for human or animal consumption. Research chemicals are intended solely for laboratory experimentation and/or in-vitro testing.  Bodily introduction of any sort is strictly prohibited by law.  All purchases are limited to licensed researchers and/or qualified professionals. All information shared in this article is for educational purposes only.

What Is BPC-157 Peptide?

What Is BPC-157 Peptide?

BPC-157 is a short peptide derived from a full-length protein called body protection compound (BPC). Researchers suggest that BPC is a naturally occurring peptide that may promote healing when exposed experimentally in animal research models. The peptide is speculated to play a crucial role in the potential repair and healing of the intestines and other tissues upon injury or insult. The mode of action of the BCP-157 peptide may be linked to the growth hormone axis and functioning, according to some hypotheses.

 

BPC-157 Peptide and Healing

BPC-157 represents a short segment of a naturally occurring protein known as body protection compound (BPC). It may be found in various tissues, such as the liver and skin, though it was first isolated from the stomach fluid, also known as the gastric juice. Previous studies may have suggested the efficacy of both BPC-157 and the parent protein BPC in potentially promoting tissue healing. New research may be focused on exploring the molecular mechanisms for the same.

 

Fibroblast Outgrowth and Migration

In vitro assays have suggested that the peptide may help prolong fibroblasts’ survival by about 1.5x longer. The cells may also tend to exhibit higher activity. Fibroblasts are motile cells found in most connective tissues. When there is an injury to tissues, fibroblasts migrate to the site to initiate the process of repair. They may also divide and reproduce to increase the number of fibroblasts available for tissue repair. In vitro research suggests that BPC-157 peptide concentrations might directly influence fibroblast migration. The highest recommended concentration of the peptide may also correlate with the potentially highest levels of fibroblasts. Scientific data suggests that the peptide is not only a potential chemoattractant for fibroblasts but may also enhance cellular migration 2.5 times the normal rate of migration. The cells may also show enhanced division by three times.

 

Genetic Modification

Previous research suggested that the BPC-157 peptide may also regulate collagen functions of fibroblasts. Fibroblasts are speculated to be responsible for collagen deposition and maintenance. Recent findings suggest that the peptide may also bring about genetic modulation in the fibroblast cells, potentially helping in increased expression of the GH receptor gene in fibroblasts. Hence, BPC-157 may also be speculated to alter the functions of the DNA.

Fibroblasts are found in the intestine, especially in connective tissues. The exposure of the peptide to injured connective tissue may enhance the response to growth hormone by increasing the receptor density, as some studies may suggest. Hence, even though the GH levels appear to remain the same, there may be greater hormone uptake at the injury site, potentially expediting the rate of healing. Ongoing studies reveal potentially greater potential impacts of the peptide than are currently known.

 

BPC-157 Peptide Research

BPC-157 peptide has been observed to potentially promote healing in various types of injuries like inflammatory bowel disease, muscle, tendon wear, and tear. A 2014 research study on animals suggested that a fraction of the healing response may be due to the increased production of GH receptors in the injured tissues upon BPC-157 peptide exposure. Various growth factors may have been involved in the tissue healing process, as some research studies speculate. Each of the proteins may function depending on the extent of the injury and specific tissue that has endured the damage. GH may be crucial for repairing damage to connective tissues like skeletal muscles, bone, cartilage, tendons, and ligaments. It may further promote the secretion of collagen, a protein that helps scaffold various connective tissues. BCP-157 peptide might be speculated to enhance the effects and recovery by recruiting GH to damaged tissues.

 

The Net Effect

BPC-157 peptide has been suggested by researchers to promote fibroblast migration, survival, division, and enhance the rate of their movement to the site of injury. Thus, the peptide might improve the rate of repair by several folds. This may be achieved through the stimulation of natural healing processes, potentially enhancing natural repair mechanisms.

 

Disclaimer: The products mentioned are not intended for human or animal consumption. Research chemicals are intended solely for laboratory experimentation and/or in-vitro testing.  Bodily introduction of any sort is strictly prohibited by law.  All purchases are limited to licensed researchers and/or qualified professionals. All information shared in this article is for educational purposes only.

Peptides and Osteoporosis

Peptides and Osteoporosis

Osteoporosis, which is characterized by an increase in bone fragility and vulnerability to fractures, is speculated to be one of the most prevalent systemic skeletal system diseases. The healing of fractures in research models of osteoporosis is delayed and compromised due to microarchitectural destruction in bone tissue. Recent studies in different animal research models have examined the impacts of three significant peptides, BPC-157, AOD 9604, and MOTS-c, in research models of osteoporosis.

 

BPC-157 and Osteoporosis

BPC-157 is a synthetic amino acid sequence of the naturally available Body Protection Complex (BPC) present in gastric juice. Researchers may suggest that BPC-157 may lead to improvement of healing in numerous types of wounds, acceleration in various forms of tissue healing, both internal and external, potential anti-inflammatory effects, among other impacts.

Intramuscular exposure to BPC-157 exhibited promising results compared to the percutaneous exposure of autologous bone marrow or autologous bone grafting (the effectiveness could also be seen after local exposure). In the light of the stomach’s significance for bone homeostasis, the potential relevance of BPC-157’s effect (local or intramuscular effectiveness, lack of unwanted effects) could be speculated as a basis for choice methods in the future management of healing impairment in animals and requires further investigation.

 

AOD-9604 and Osteoporosis

AOD-9604 is a peptide that consists of a fragment of growth hormone without apparent proliferative effects, which researchers may speculate has multiple effects on bone. The IGF-1 and direct cellular pathways are suggested to be activated by AOD-9704, which is approximately 8% of the growth hormone molecule. AOD-9604 is suggested not to exhibit any effect on the IGF-1 pathway, which may result in significant insulin resistance. This product has been suggested to be utilized with increasing success in the potential research of local pain like osteoarthritis and tendonitis.

South Korean researchers investigated the potential effects of AOD-9604 via intra-articular exposures with or without hyaluronic acid in a collagenase-induced knee osteoarthritis rabbit model. Each exposure was given for 4-7 weeks after the first intra-articular collagenase exposure. The degree of cartilage degeneration was then assessed using the morphological and histopathological findings. Eight weeks after the first collagenase exposure, the degree of lameness was also potentially observed. The intra-articular AOD9604 exposures using ultrasound guidance have been suggested to show enhanced cartilage regeneration. The combination of AOD9604 and HA exposures has been suggested to be more effective than AOD9604 or HA exposure alone in the collagenase-induced knee OA rabbit model.

 

What is MOTS-c?

Thirty-seven known genes, including 22 tRNAs, 2rRNAs, and 13 polypeptide subunits of the electron transport chain complexes, are encoded by mitochondrial DNA (mtDNA). Recent research studies suggest small open reading frames in the rRNA loci that may be transcribed and translated into short peptides called mitochondrial-derived peptides (MDPs), which may exhibit biological activity. MOTS-c is a mitochondrial-encoded peptide with 16-aa’s encoded within the 12S rRNA locus of mtDNA in cells.

MOTS-c may translocate into the nucleus in response to metabolic stress and regulation of adaptive nuclear gene expression. This may allow the peptide to promote resistance to metabolic stress by upregulating the mitochondrial genome. Upregulating these genes may encourage mitochondrial biogenesis. AMPK, if activated, may restore homeostasis by potentially initiating catabolic processes for ATP production in case of energy deficits. In addition, some research papers may suggest that MOTS-c potentially decreases insulin resistance and increases GLUT4 uptake in muscle.

 

Disclaimer: The products mentioned are not intended for human or animal consumption. Research chemicals are intended solely for laboratory experimentation and/or in-vitro testing.  Bodily introduction of any sort is strictly prohibited by law.  All purchases are limited to licensed researchers and/or qualified professionals. All information shared in this article is for educational purposes only.

Epitalon: Correlation in DNA Telomeres and Sleep

Epitalon: Correlation in DNA Telomeres and Sleep

Research studies in 1973 suggest that the exposure to Epithalamin was followed by a restoration of the estrous cycle in old female rats with persistent estrus syndrome. This might have lowered the threshold of sensitivity of the hypothalamo-pituitary complex to feedback inhibition by estrogens in old animals. The long-term exposure to the preparation has been suggested to prolong the animal’s life span, slow down the aging of cells in the reproductive system, improve parameters of immune function, and inhibit the development of spontaneous tumors induced by some chemicals or X-irradiation and transplanted tumors.

 

Studies on Epitalon and Circadian Rhythms

The night release of endogenous melatonin have been associated with peptide production in the pineal gland, and the circadian hormone rhythm may be normalized in the blood plasma. Research models of pineal gland dysfunction might exhibit an increase in the night melatonin level, for which Epithalamin and Epithalon may exert modulatory effects. The pineal gland preparations may potentially increase melatonin concentration.

 

Pituitary Gland and Rapid Cell Aging

Epithalamin was given along with the regular courses in 39 research models of coronary dysfunction, while 40 models (control group) received standard procedures. Long-term exposure to epithalamin (six courses over three years) resulted in an apparent decrease in the aging of the cells in the cardiovascular system, possible prevention of age-associated impairment of physical endurance, and normalization of the circadian rhythm of melatonin production, lipid, and carbohydrate metabolism. The geroprotective potential of the peptide from the pineal gland were posited, and research models exposed to epithalamin exhibited a significant decrease in mortality rates compared to controls.

 

Epitalon and Chromatin

The function of chromatin is to protect the DNA structure and sequence and effectively pack DNA into a small volume to fit into the nucleus of a cell. The activation of ribosomal genes, decondensation of pericentromeric structural heterochromatin, and the release of genes repressed due to the age-related condensation of euchromatic chromosome regions might be induced by Epitalon. Thus, Epitalon may have potential to activate chromatin by modifying the heterochromatin and heterochromatinized chromosome regions in aged cells.

 

Telomerase Elongation and the Hayflick Limit

Each cell consists of DNA as an instructional guide showing how to divide and grow. The telomeres shield the DNA inside each cell. The exposure of Epitalon to functional cells may have exhibited increase the telomerase enzyme, which strengthens telomeres; an approximate increase of 33% was observed in the length of the telomeres.

 

White Blood Cells

Melatonin may prevent age-specific decreases in the levels of blood lymphocytes in the standard photoperiod. In contrast to melatonin, Epitalon appeared to have significantly reduced the lymphocyte count and increased the neutrophil count in some age periods. During cell aging, there might have been an increase in the leukocytes’ alkaline phosphatase activity. As compared with other light conditions, constant light was suggested to promote an early increase in the alkaline phosphatase activity (at 12 months), associated with accelerated development of the pathological process in the organism.

 

Disclaimer: The products mentioned are not intended for human or animal consumption. Research chemicals are intended solely for laboratory experimentation and/or in-vitro testing.  Bodily introduction of any sort is strictly prohibited by law.  All purchases are limited to licensed researchers and/or qualified professionals. All information shared in this article is for educational purposes only.

Sermorelin Studies and Growth Hormone

Sermorelin Studies and Growth Hormone

Comparing Sermorelin and Growth Hormone

Sermorelin, a member of the peptide group known as the Growth Hormone-Releasing Hormone Analogues, might contribute to improving wound healing, hunger hormone signaling, bone density, cell age mitigation, and maintaining endogenous growth hormone production in periods of natural decline. It is considered an interesting peptide for researchers, especially working in domains related to hGH and anti-aging of cells, and has been suggested for potential as a testing reagent in animals. The reasons why this is considered an interesting peptide are mentioned below.

Growth hormone (hGH) supplementation has been researched in cases of growth hormone deficiency. Although there have been speculative advances in the production methods of hGH, several risks are still speculated to be associated with its exposure in research models. Unintended ancillary impacts associated with hGH might include joint pains, an increased risk of diabetes, swelling in joints, and increased risks of some types of cancer. The reason behind the speculated effects associated with the supplementation of hGH is because it may disrupt the normal physiological feedback mechanisms. Two things might happen due to the interruption of the normal controls on the secretion of hGH. First, there might be a much more abrupt rise and fall in the hGH levels, affecting the response of organs and tissues to the peptides and potentially elevating the risks associated with hGH high levels. This phenomenon is speculated to be known as square-wave physiology.

The second speculated reason associated with unintended and potentially detrimental ancillary action is the suppression of feedback mechanisms due to high hGH levels, which might destroy the normal 24 hours pattern of hGH secretion. Sermorelin peptide exposure has been suggested to mitigate both the problems associated with supplemented hGH. Sermorelin acetate appears to be subjected to normal physiologic feedback mechanisms, and thereby, the normal patterns of hGH secretion may be maintained. Sermorelin peptide might maintain the normal pattern and, at the same time, boost the hGH set point.

Another reason for preferring Sermorelin acetate over hGH is that with time, the hGH-deficient organism often acquires resistance to hGH, and hence the effect of the peptide is may be reduced or lost. This phenomenon might result from the decrease in the number of receptors for a given ligand and is known as tachyphylaxis. Too much hGH over a prolonged period of time results in a decrease in the number of hGH receptors, which finishes the effect of hGH. The only way to overcome this effect is considered to be the halting of supplementation to allow the recovery of the receptors. Research studies might suggest that Sermorelin peptide may potentially not be subjected to tachyphylaxis; its exposure might increase GHRH-Rs.

 

Sermorelin Acetate and Body Composition

Sermorelin acetate might favor lean body mass over fat mass, which exemplifies an apparent aspect of peptides in encouraging bone growth and muscle growth over the deposition of fat. Hypogonadism might be particularly problematic in animals who experience speculated increased effects of lack of sex hormones. Sermorelin peptide acetate is also speculated to be explored for reversing muscle atrophy other than testosterone, which is considered a strong standard of mitigating hypogonadism.

 

Sermorelin Acetate and Wound Healing

Sermorelin peptide has been suggested to have positive effects on wound healing rates. Sermorelin peptide might help in reducing scar formation. Scars leading to wound healing may potentially cause tissue- and organ-level dysfunction. Scarring (fibrosis) of the heart is troublesome as the scars in cardiac tissue might interfere with the heart’s ability to conduct electrical impulses and contract efficiently and correctly. Some research studies in animal models have suggested Sermorelin’s potential to protect heart cells from death, improve blood vessel growth, increase the production of extracellular matrix components, and reduce inflammatory cytokine levels. All of these factors might reduce the size of scars following cardiac injury, which thereby might improve cardiac functioning.

 

Disclaimer: The products mentioned are not intended for human or animal consumption. Research chemicals are intended solely for laboratory experimentation and/or in-vitro testing.  Bodily introduction of any sort is strictly prohibited by law.  All purchases are limited to licensed researchers and/or qualified professionals. All information shared in this article is for educational purposes only.

Overview of Ipamorelin and Peptide Research

Overview of Ipamorelin and Peptide Research

Ipamorelin is a derivative of the growth hormone-releasing peptide-1, which is derived from the natural protein hormone ghrelin. Ghrelin is often termed the hunger hormone. The stomach produces ghrelin, and its exposure appears to stimulate caloric intake. The cells in the anterior pituitary gland are speculated to be activated by ghrelin, which might increase the levels of growth hormone and neuropeptide Y. Ghrelin is of speculated significant value in cognitive function, energy metabolism, and may influence the sleep-wake cycle.

Peptide Sequence: Aib-His-D-2Nal-D-Phe-Lys

Molecular Formula: C38H49N9O5

Molecular Weight: 711.868 g/mol

 

Ipamorelin Peptide Mode of Action

The GHS receptor, also called the ghrelin receptor, is highly expressed in the anterior pituitary gland and hypothalamus. Growth hormone is released from the anterior pituitary gland as the agonists bind to the GHS-R in the pituitary gland. Five of the most active GHS-R binding amino acids appear to be present in Ipamorelin, making this short peptide the smallest known GHS-R agonist. The exposure to Ipamorelin in animal models reportedly resulted in the stimulation and the release of neuropeptide Y, which may lead to an increased appetite, decreased pain perception, and changes in energy metabolism.

 

Food Intake

The specific receptors required for stimulating the release of neuropeptide Y are situated in the hypothalamus, and the binding to the GHS-R might trigger the release of this peptide. The release of neuropeptide Y is associated with an increase in food intake. Therefore, it might alter food preferences, thereby increasing the storage of energy as fat.

 

Pain Perception

Research suggests the potential of Ipamorelin in reducing neuropathic pain, the pain associated with nerve dysfunction, and reducing visceral pain, the gastrointestinal tract, and organ pain. Research studies in rats indicate a reduction in pain perception by as much as 2-fold.

 

Bone

Some research studies in rats suggest an association of Ipamorelin with the regulation of bone turnover and promotion of mineralization of existing bones and the formation of new bones. Research in rats suggests the effectiveness of Ipamorelin in offsetting the effects of substances like corticosteroids and certain conditions considered to compromise bone density and increase bone formation by as much as four-fold. In addition, Ipamorelin has been suggested to prevent aberrant fat deposition seen with high corticosteroid levels and prevent bone loss.

 

Ipamorelin Peptide & Heart Function

The relationship between ghrelin and heart function is a complicated one. However, research in cell cultures and research in animal models indicate that ghrelin may help protect the heart after a heart attack or other cardiac damages. Furthermore, it might also be that ghrelin produced in minute amounts in the vascular system may help in reducing the scar formation and the successive hypertrophy of the heart. This might thereby put a stop to the long-term consequences of heart damage and also heart failure.

 

Gender Differences in Ipamorelin Peptide Responses

Research studies conducted in mice, rats, and pigs suggest that the peptide may exhibit objectively larger benefits in females than males. The relative lack of testosterone in females compared to males has been hypothesized to be the foundation for why the peptide may potentially be more effective in females. The lower levels of testosterone have been associated with a decrease in muscle anabolism and lower bone mineral density. Research studies are ongoing to confirm any other reasons associated with the higher potential effectiveness of the peptide in females.

 

Disclaimer: The products mentioned are not intended for human or animal consumption. Research chemicals are intended solely for laboratory experimentation and/or in-vitro testing.  Bodily introduction of any sort is strictly prohibited by law.  All purchases are limited to licensed researchers and/or qualified professionals. All information shared in this article is for educational purposes only.